Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £238.99m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Transaction in Own Shares

24 May 2022 17:31

RNS Number : 6688M
Science Group PLC
24 May 2022
Β 

Β 

24 May 2022

Β 

Science Group plc

(the "Company" or "Science Group")

Β 

Transaction in own shares

Β 

Science Group plc (AIM:SAG) announces that, on 24 May 2022, it purchased 4,709 of its 1 pence ordinary shares at an average price of 402.0270 pence per share. The highest price paid per share was 405.0 pence and the lowest price paid per share was 398.0 pence. The Company purchased these shares through Liberum Capital Limited.

Β 

The number of shares purchased represented 0.01% of the voting rights attributable to the total ordinary shares in issue prior to the purchase. The purchased shares will be held in treasury.

Β 

The total number of ordinary shares in issue (excluding treasury shares) following this announcement is 45,503,490. Science Group holds 682,384 shares in treasury and a further 104,400 shares are held by the Frontier Smart Technologies Employee Benefit Trust. The total number of voting rights in the Company following this announcement is therefore 45,399,090.

Β 

The figure of 45,399,090 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure and Transparency Rules.

Β 

Schedule of Purchases - Individual Transactions

Β 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Liberum Capital Limited on behalf of the Company as part of the buyback programme.

Β 

Number of shares purchased

Transaction price (per share)

Time of transaction

Execution venue

1209

2000

500

1000

405.0

398.0

405.0

405.0

13:15:34

16:25:21

16:27:40

16:27:51

AIMX

AIMX

AIMX

AIMX

Β 

Β 

- Ends -

Β 

For further information:

Science Group plc

Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

Β 

www.sciencegroup.com Β 

Stifel Nicolaus Europe Limited (Nominated Adviser and Joint Broker)

Nick Adams, Alex Price, Richard Short

Tel: +44 (0) 20 7710 7600

Liberum Capital Limited (Joint Broker)

Neil Patel, Cameron Duncan

Tel: +44 (0) 20 3100 2000

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
POSBKQBNABKDKPB
Date   Source Headline
6th Oct 20257:00 amRNSTransaction in Own Shares
3rd Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
1st Oct 20257:00 amRNSTotal Voting Rights
30th Sep 20257:00 amRNSHolding(s) in Company
29th Sep 202512:00 pmRNSTreasury shares issued
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:01 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTreasury shares issued
19th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:01 amRNSHolding(s) in Company
5th Sep 20257:00 amRNSChairman Shareholding
2nd Sep 20252:20 pmRNSHolding(s) in Company
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 20257:00 amRNSTotal Voting Rights
22nd Aug 20257:00 amRNSTransaction in Own Shares
21st Aug 20257:00 amRNSTransaction in Own Shares
20th Aug 20257:00 amRNSTransaction in Own Shares
19th Aug 20257:00 amRNSTransaction in Own Shares
18th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 20257:00 amRNSTransaction in Own Shares
28th Jul 20257:01 amRNSInterim results for 6 months ended 30 June 2025
28th Jul 20257:00 amRNSTransaction in Own Shares
24th Jul 20257:00 amRNSTransaction in Own Shares
18th Jul 20257:00 amRNSTransaction in Own Shares
16th Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20257:01 amRNSChange of Adviser & Notice of Interim Results
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 20257:00 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:00 amRNSTransaction in Own Shares
27th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.